1-4 of 4
D. Suffredini
Close
Sort by
Journal Articles

Allograft Cell Content and GVHD Differ in Murine Recipients of AMD3100 Versus G-CSF Mobilized Peripheral Blood Stem Cells.

A. Lundqvist, PhD, N. Hamoui, J. Andersson, PhD, M. Elshal, PhD, Y. Takahashi, MD, PhD, R. Srinivasan, MD, PhD, D. Suffredini, P. J. McCoy, Jr., PhD, R. Childs, MD
Journal: Blood
Blood (2005) 106 (11): 3108.
https://doi.org/10.1182/blood.V106.11.3108.3108
Published: 2005
Journal Articles

Durable Engraftment and Long-Term Survival Following Fludarabine-Based Nonmyeloablative Hematopoietic Cell Transplantation (HCT) in Patients with ATG-Refractory Severe Aplastic Anemia (SAA) and Other Nonmalignant Hematological Disorders.

Sakti Chakrabarti, Y. Takahashi, R. Srinivasan, I. Espinoza, T. Igarashi, D. Suffredini, M. Marquesen, R. A. Shalabi, C. D. Bolan, S. F. Leitman, A. J. Barrett, N. S. Young, R. Childs
Journal: Blood
Blood (2004) 104 (11): 252.
https://doi.org/10.1182/blood.V104.11.252.252
Published: 2004
Journal Articles

Complex Alterations in Serum Cytokines and Increased Il-4 Levels Characterize Patients Developing Chronic Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.

M. Elshal, Y. Takahashi, S. Chakrabarti, R. Srinivasan, D. Suffredini, T. Igarashi, S. Solomon, A. Lundqvist, A. J. Barrett, J. P. McCoy, Jr, Richard Childs
Journal: Blood
Blood (2004) 104 (11): 4985.
https://doi.org/10.1182/blood.V104.11.4985.4985
Published: 2004
Journal Articles

The Graft-vs-Host Hematopoietic Effect Generated after Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) Cures Patients with Severe PNH.

Yoshiyuki Takahashi, MD, PhD, S. Chakrabarti, MD, R. Srinivasan, MD, PhD, T. Igarashi, MD, PhD, A. Lundqvist, PhD, I. Espinoza, MD, D. Suffredini, J.P. McCoy, Jr., PhD, A.J. Barrett, MD, N.S. Young, MD, Richard Childs, MD
Journal: Blood
Blood (2004) 104 (11): 811.
https://doi.org/10.1182/blood.V104.11.811.811
Published: 2004